Facility Design and Engineering

Samsung BioLogics begins construction on their third facility in Songdo, Korea.

Biogen, Genentech, Johnson & Johnson, Novartis, and Patheon publicize their support for action on climate change.

GE Healthcare's KUBio prebuilt modules were shipped from Germany to JHL Biotech in Wuhan, China.

Hiroaki Suzuki will lead Vetter’s business activities in the new Tokyo-based office.

The National Biologics Manufacturing Centre will provide companies with open access to bioprocessing facilities and expertise to expedite low-risk market entry of complex biologics.

Preventing contamination requires quality systems to be in place, including routine cleaning, a robust cleaning validation program, and preventive maintenance.

According to AstraZeneca, the purchase of the biologics bulk plant will double the company's biologics manufacturing capacity in the US.

Reuters reports that Novo Nordisk will invest 500 million Danish Krone (approximately $75 million US dollars) into a new 19,000 m2 warehouse in Hillerød, Denmark. The warehouse will handle all inbound raw materials for Novo Nordisk's production in Denmark and will have a capacity of around 17,000 pallets of product, according to the news outlet.

The author discusses the current best practices in technical qualification of single-use systems.

Biopharmaceutical company BeiGene plans to build facility in Suzhou to expand its clinical capability and prepare for commercial manufacturing.

Industry experts discuss challenges, trends, and innovations in fluid handling.

Biogen plans to build a biologics manufacturing plant in northwest Switzerland using next-generation technologies to create efficiency and sustainability.

The new facility expands the company’s commercial manufacturing capability at its Bend, Ore. site.

Australian company, Genea Biocells, will open a facility in San Diego, California for cell and culture-media manufacturing and R&D.

Lonza’s planned facility will be used to develop and manufacture viral gene therapies and virally modified cell therapies

Single-use and modular technologies plus continuous manufacturing are increasingly important to biopharma scale-up and tech transfer.

The costs and benefits of integrating modular concepts for on-demand bioprocessing are explored.

Prequalified manufacturing suites could benefit from a new business model, say some industry executives.

Facilities in China, Ireland, Germany, and the United States have been recognized by ISPE in the 2015 Facility of the Year Awards program.

The upgrades will offer the opportunity for higher product yields and higher purity levels.

Baxter announced that its new biopharmaceutical arm, scheduled to become independent from Baxter in 2015, will be located in Bannockburn, Illinois.

The multi-product biopharmaceutical manufacturing facility is scheduled to start up in 2017.

The new location will increase Bristol-Myers Squibb's biologics manufacturing capacity.

Sartorius opened a new application center at its offices in Shanghai for product demonstrations, trial runs, and training sessions.

The renovation to Roche's historic office building in Basel, Switzerland will feature sustainable workplaces and a state-of-the-art research center.

Experts discuss the future of modular manufacturing and the challenges that biopharma manufacturers face in facility design

Walker Barrier Systems builds eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing.

GE Healthcare Life Sciences announced that it will build a KUBio modular biopharmaceutical factory in China for JHL Biotech.

BioPharm International spoke with INTERPHEX 2013 conference-session presenters to gain insight on trends in facility and process design.

Additional challenges to the new cleanroom paradigm from concurrent multiproduct manufacturing of bulk drug substances in a controlled non-classified (CNC) ballroom environment.